Most Common Security Breaches in Biotech
By Esteban Sardanyés on Apr 6, 2026 10:00:00 AM

Currently, a security breach in the biotech sector can have an average impact of $4.82 million. But it’s not just about the financial loss: these breaches can also compromise data integrity, disrupt organizational operations, halt clinical trials, or create regulatory and compliance risks that directly affect the viability of your biotech company.
Most Common Security Breaches in Biotech Organizations
Malware and Ransomware
Malware, including trojans and ransomware, is a constant threat to laboratories and biotech companies. Trojans hide within seemingly legitimate programs to steal information or open unauthorized network access, compromising sensitive data and critical systems.
Real Case Example (Bayer)
Victims of a malware cyberattack that escalated to ransomware, attributed to the Wicked Panda group, aimed at industrial espionage and theft of sensitive research data.
Ransomware encrypts files and systems, blocking access until a ransom is paid. In biotech, this can halt research, affect lab results, and put patient and collaborator data at risk, in addition to causing financial losses and operational delays.
Real Case Example (Enzo Biochem)
In 2023, Enzo Biochem suffered a ransomware attack that affected its systems and exposed data and clinical trials of approximately 2.47 million individuals.
Phishing and spear phishing
Phishing remains one of the main access vectors in biotech environments, but its evolution has significantly increased its impact. Current campaigns are personalized, tailored to the organization’s context, and designed to compromise credentials, critical access, or sensitive data without raising suspicion.
Adopting anti-phishing solutions and awareness measures is no longer a recommendation—it’s essential to reduce real compromise risk.
While phishing is broad-based, spear phishing targets specific individuals or teams, using personalized information to increase success probability. Human error remains the most common entry point, so employee training and awareness are critical for mitigating these risks.
Real Case Example (Levitas Capital)
In 2020, Levitas Capital fell victim to a spear phishing campaign via a fake link. The attack allowed cybercriminals to steal funds and send impersonated emails from the compromised account.
Data Leaks and Theft
Information leaks can result from external attacks, internal errors, or security system failures. In biotech, biomedical and personal data are extremely sensitive: exposure can lead to loss of trust, legal penalties, and reputational damage.
Not all leaks come from outside. Sometimes an employee leaving the organization may inadvertently or intentionally take critical information. Tools like WWatcher allow monitoring and limiting file downloads by user role and activity, detect unusual behavior, and prevent internal leaks before they cause real impact.
Supply Chain Attacks
Cybercriminals exploit the supply chain to infiltrate an organization’s infrastructure. They may introduce malware through vendors, conduct social engineering or impersonation attacks, intercept information, or even gain unauthorized physical access.
These breaches not only threaten IT systems but can also disrupt critical research and production processes, affecting business continuity.
Real Case Example (MANGO)
In 2025, Mango suffered a cyberattack through its supply chain when one of its external marketing service providers was compromised. The attack allowed cybercriminals to leak customers’ personal data, such as names, phone numbers, and emails, which was later used for phishing and impersonation campaigns.
Vulnerabilities in IoT and OT Devices
Laboratories and biotech companies increasingly rely on IoT (Internet of Things) and OT (operational technology) devices for automated processes. Without proper security measures, these devices can become entry points for attacks that disrupt operations or even cause sabotage.
Protecting them is crucial to maintain operational efficiency and data security.
Essential Security Measures to Protect Your Biotech Company
1. Network and System Segmentation
Separate research networks from corporate and administrative systems. This limits access to critical information and reduces the risk that an attack in one part of the company affects the entire infrastructure. Use micro-segmentation tools and firewall policies to enforce restrictions by department or project.
2. Access Control and Passwords
Not all employees need the same level of access. Apply multi-factor authentication and strong passwords, regularly reviewing who has permissions for critical systems or sensitive data.
3. Backups and Recovery
Regularly back up critical systems and data, including clinical trials and lab results. Ensure backups are encrypted and can be restored quickly in the event of an incident to prevent operational paralysis or data loss.
4. Internal Leak Monitoring with WWatcher
Not all breaches come from outside. Employees changing positions or leaving the company may inadvertently or intentionally take critical information. Tools like WWatcher can detect unusual downloads, limit volumes by role, and generate early alerts to prevent internal leaks before they have real impact.
5. Employee Education and Awareness
The human factor remains the most common entry point for attacks. Ongoing training on phishing, ransomware, and data handling best practices significantly increases your biotech’s resilience and reduces operational and regulatory risks.
ESED, Your Cybersecurity Partner
Implementing cybersecurity measures is not just a recommendation—it’s a critical strategy to protect sensitive data, ensure operational continuity, and maintain the trust of clients, partners, and regulators. Every preventive action reduces the likelihood of incidents and allows your biotech to grow safely and efficiently in an increasingly competitive environment.
Calculate the real impact of a cyberattack on your company with our cyberattack cost tool. Assess potential losses from operational disruption, data theft, and regulatory penalties, and obtain objective data to make decisions that strengthen your systems’ security.







